CHARACTERISTICS, DETECTION AND TYPING METHODS OF COMMUNITY ACQUIRED METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS (CA-MRSA) – A REVIEW

Authors

  • Lia Natasha Amit Biotechnology Research Institute, Universiti Malaysia Sabah, Jalan UMS, 88400, Kota Kinabalu, Sabah, Malaysia
  • Fong Siew Moy Infection Control Unit, Hospital Wanita dan Kanak-Kanak Sabah, KarungBerkunci 187, 88996, Kota Kinabalu, Sabah, Malaysia
  • Daisy Vanitha John Biotechnology Research Institute, Universiti Malaysia Sabah, Jalan UMS, 88400, Kota Kinabalu, Sabah, Malaysia

DOI:

https://doi.org/10.37268/mjphm/vol.17/no.3/art.231

Keywords:

CA-MRSA, prevalence, transmission, PVL toxin, SCCmec, spa typing, PFGE, MLST

Abstract

Staphylococcus aureus aregram positive cocci which colonizethe skin and mucous membranes particularly the anterior nares. Prevalence of nosocomial infections associated with methicillin resistant S. aureus have been reported in hospitals (HA-MRSA) for over five decades. Recently,community-acquired MRSA (CA-MRSA) has emerged as a cause of skin and soft tissue infections in healthy individuals. These strains are sensitive to antimicrobials, carry genes for Panton-Valentine leukocidin (PVL) toxin and belong to the staphylococcal cassette chromosome (SCC) mec type IV or V. The suspected mode of transmission involves close contact with carriers leading to skin or nasal colonization that resultin subsequent active infection. Molecular typing is used to determine the mode of transmission of CA-MRSA in the community.General typing methods such as pulsed-field gel electrophoresis (PFGE) and multilocus sequence typing (MLST) and specific methods for Staphylococci such as SCCmec typing and spa typing have the capability to characterize bacterial chromosomes and mobile genetic elements. Combination of these molecular typing methods is necessary as each method has its own advantages with respect to discriminatory power, rapidity, cost effectiveness, reproducibility, and ease of performance.

References

1. Lowy FD. Staphylococcus aureus infections. N Engl J Med 1998;339(8):520-32.

2. Barber M, Rozwadowska-Dowzenko M. Infection by penicillin- resistant staphylococci. Lancet 1948;2(6530):641-44.

3. Panlilio AL, Culver DH, Gaynes RP, et al. Methicillin-resistant Staphylococcus aureus in US hospitals, 1975–1991. Infect Control Hosp Epidemiol 1992;13(10):582-86.

4. Rosenthal VD, Bijie H, Maki DG, et al. International Nosocomial Infection Control Consortium (INICC) report, data summary of 36 countries, for 2004-2009. Am J Infect Control 2012;40(5):396-07.

5. Sowash MG, Uhlemann AC. Community- associated methicillin-resistant Staphylococcus aureus case studies. Methods Mol Biol 2014; 1085:25-69.

6. Herold BC, Immergluck LC, Maranan MC, et al. Community-acquired methicillin- resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA 1998; 279:593–98.

7. O’Brien FG, Lim TT, Chong FN, et al. Diversity among community isolates of methicillin-resistant Staphylococcus aureus in Australia. J Clin Microbiol 2004;42(7):3185-90.

8. Millar BC, Loughrey A, Elborn JS, Moore JE. Proposed definitions of community- associated meticillin-resistant Staphylococcus aureus (CA-MRSA). J Hosp Infect 2007; 67(2):109-13.

9. Udo EE, Pearman JW, Grubb WB. Genetic analysis of community isolates of methicillin-resistant Staphylococcus aureus in Western Australia. J Hosp Infect 1993;25(2):97-108.

10. Centers for Disease Control and Prevention (CDC). Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus—Minnesota and North Dakota, 1997-1999. MMWR Morb Mortal Wkly Rep 1999;48(32):707-10.

11. Baggett HC, Hennessy TW, Rudolph K, et al. Community-onset methicillin-resistant Staphylococcus aureus associated with antibiotic use and the cytotoxin Panton- Valentine leukocidin during a furunculosis outbreak in rural Alaska. J Infect Dis 2004;189(9):1565-73.

12. Centers for Disease Control and Prevention (CDC). Community-associated methicillin- resistant Staphylococcus aureus infections in Pacific Islanders-Hawaii, 2001-2003. MMWR Morb Mortal Wkly Rep 2004;53(33):767-70.

13. Song JH, Hsueh PR, Chung DR, et al. Spread of methicillin-resistant Staphylococcus aureus between the community and the hospitals in Asian countries: an ANSORP study. J Antimicrob Chemother 2011;66(5):1061-69.

14. Huang YC, Ho CF, Chen CJ, Su LH, Lin TY. Comparative molecular analysis of community?associated and healthcare? associated methicillin?resistant Staphylococcus aureus isolates from children in northern Taiwan. Clin Microbiol Infect 2008;14(12):1167-72.

15. Sam IC, Kahar-Bador M, Chan YF, Loong SK, Ghazali FMN. Multisensitive community- acquired methicillin-resistant Staphylococcus aureus infections in Malaysia. Diagn Microbiol Infect Dis 2008;62(4):437-39.

16. Rashid ZZ, Bahari N, Othman A, et al. Community-acquired methicillin-resistant Staphylococcus aureus in a Malaysian tertiary centre. Southeast Asian J Trop Med Public Health 2013;44(1):104-08.

17. Ghaznavi-Rad E, Shamsudin MN, Sekawi Z, et al. Predominance and emergence of clones of hospital-acquired methicillin- resistant Staphylococcus aureus in Malaysia. J Clin Microbiol 2010;48(3):867-72.

18. Ahmad N, Ruzan IN, Ghani MKA, et al. Characteristics of community and hospital acquired methicillin-resistant Staphylococcus aureus strains carrying SCCmec type IV isolated in Malaysia. J Med Microbiol 2009;58(9):1213-18.

19. Chen CJ, Hsueh PR, Su LH, et al. Change in the molecular epidemiology of methicillin- resistant Staphylococcus aureus bloodstream infections in Taiwan. Diagn Microbiol Infectious Dis 2009;65(2):199-01.

20. Pannaraj PS, Hulten KG, Gonzalez BE, Mason EO, Kaplan SL. Infective pyomyositis and myositis in children in the era of community-acquired, methicillin-resistant Staphylococcus aureus infection. Clin Infect Dis 2006;43(8):953-60.

21. Adem PV, Montgomery CP, Husain AN, et al. Staphylococcus aureus sepsis and the Waterhouse–Friderichsen syndrome in children. N Engl J Med 2005;353(12):1245- 51.

22. Miller LG, Perdreau-Remington F, Rieg G, et al. Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles. N Engl J Med 2005;352(14):1445-53.

23. Kravitz GR, Dries DJ, Peterson ML, Schlievert PM. Purpura fulminans due to Staphylococcus aureus. Clin Infect Dis 2005;40(7):941-47.

24. Shopsin B, Kreiswirth BN. Molecular epidemiology of methicillin-resistant Staphylococcus aureus. Emerg Infect Dis 2001;7(2):323-26.

25. Vandenesch F, Naimi T, Enright MC, et al. Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton- Valentine leukocidin genes: worldwide emergence. Emerg Infect Dis 2003;9(8):978-84.

26. Boyle-Vavra S, Daum RS. Community- acquired methicillin-resistant Staphylococcus aureus: the role of Panton– Valentine leukocidin. Lab Invest 2007;87(1):3-9.

27. Katayama Y, Ito T, Hiramatsu K. A new class of genetic element, staphylococcus cassette chromosome mec, encodes methicillin resistance in Staphylococcus aureus. Antimicrob Agents Chemother 2000;44(6):1549-55.

28. Katayama Y, Ito T, Hiramatsu K. Genetic organization of the chromosome region surrounding mecA in clinical staphylococcal strains: role of IS431-mediated mecI deletion in expression of resistance in mecA-carrying, low-level methicillin- resistant Staphylococcus haemolyticus. Antimicrob Agents Chemother 2001;45(7):1955-63.

29. IWG-SCC. International Working Group on the Staphylococcal Cassette Chromosome elements [cited 2016 May 17]. Available from: www.SCCmec.org/Pages/SCC_TypesEN.ht ml

30. Ito T, Okuma K, Ma XX, Yuzawa H, Hiramatsu K. Insights on antibiotic resistance of Staphylococcus aureus from its whole genome: genomic island SCC. Drug Resist Updat 2003;6(1):41-52.

31. Lina G, Piémont Y, Godail-Gamot F, et al. Involvement of Panton-Valentine leukocidin—producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis 1999;29(5):1128-32.

32. Gillet Y, Issartel B, Vanhems P, et al. Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet 2002;359(9308):753-59.

33. Gonzalez BE, Martinez-Aguilar G, Hulten KG, et al. Severe staphylococcal sepsis in adolescents in the era of community- acquired methicillin-resistant Staphylococcus aureus. Pediatrics 2005;115(3):642-48.

34. Bocchini CE, Hulten KG, Mason EO, et al. Panton-Valentine leukocidin genes are associated with enhanced inflammatory response and local disease in acute hematogenous Staphylococcus aureus osteomyelitis in children. Pediatrics 2006;117(2):433-40.

35. Gerald WT. Medical Importance of the Normal Microform. 1st ed. US: Springer;1999.

36. Williams RE. Skin and nose carriage of bacteriophage types of Staph aureus. J Pathol Bacteriol 1946;58:259-68.

37. Martin TD, Whitehead JE. Carriage of penicillin-resistant Staph. pyogenes in healthy adults. Br Med J 1949;1(4595):173- 75.

38. Guinan ME, Dan BB, Guidotti RJ, et al. Vaginal colonization with Staphylococcus aureus in healthy women: a review of four studies. Ann Intern Med 1982; 96:944-47.

39. Ridley M. Perineal carriage of Staph. aureus. Br Med J 1959;1(5117):270-73.

40. Jacobs SI, Williamson GM, Willis AT. Nasal abnormality and the carrier rate of Staphylococcus aureus. J Clin Pathol 1961; 14:519-21.

41. Noble WC, Williams RE, Jevons MP, Shooter RA. Some aspects of nasal carriage of staphylococci. J Clin Pathol 1964; 17:79- 83.

42. Kluytmans J, Van Belkum A, Verbrugh H. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev 1997; 10(3):505-20.

43. Lee J, Sung JY, Kim YM, et al. Molecular characterization of methicillin-resistant Staphylococcus aureus obtained from the anterior nares of healthy Korean children attending daycare centers. Int J Infect Dis 2011;15(8): e558-63.

44. Ho PL, Chiu SS, Chan MY, et al. Molecular epidemiology and nasal carriage of Staphylococcus aureus and methicillin- resistant S. aureus among young children attending day care centers and kindergartens in Hong Kong. J Infect 2012;64(5):500-06.

45. Huang YC, Hwang KP, Chen PY, Chen CJ, Lin TY. Prevalence of methicillin-resistant Staphylococcus aureus nasal colonization among Taiwanese children in 2005 and 2006. J Clin Microbiol 2007;45(12):3992-95.

46. Esperson F, Clemmensen I. Isolation of a fibronectin-binding protein from Staphylococcus aureus. Infect Immun 1982;37(2):526-31.

47. Aly R, Shinefield HR, Litz C, Maibach HI. Role of teichoic acid in the binding of Staphylococcus aureus to nasal epithelial cells. J Infect Dis 1980;141(4):463-65.

48. Light IJ, Sutherland JM, Cochran ML, Sutorius J. Ecologic relation between Staphylococcus aureus and Pseudomonas in a nursery population: Another example of bacterial interference. N Engl J Med 1968;278(23):1243-47.

49. Aly R, Shinefield HI, Strauss WG, Maibach HI. Bacterial adherence to nasal mucosal cells. Infect Immun 1977;17(3):546-49.

50. Armstrong-Esther CA, Smith JE. Carriage patterns of Staphylococcus aureus in a healthy non-hospital population of adults and children. Ann Hum Biol 1976;3(3):221- 27.

51. Millian SJ, Baldwin JN, Rheins MS, Weiser HH. Studies on the incidence of coagulase- positive staphylococci in a normal unconfined population. Am J Public Health Nations Health 1960; 50:791-98.

52. Kinsman OS, Mckenna R, Noble WC. Association between histocompatability antigens (HLA) and nasal carriage of Staphylococcus aureus. J Med Microbiol 1983;16(2):215-20.

53. Feinstein V, Musher DM, Cate TR. Bacterial adherence to pharyngeal cells during viral infection. J Infect Dis 1980;141(2):172-76.

54. Heysell SK, Shenoi SV, Catterick K, Thomas TA, Friedland G. Prevalence of methicillin- resistant Staphylococcus aureus nasal carriage among hospitalised patients with tuberculosis in rural Kwazulu-Natal. S Afr Med J 2011;101(5):332-34.

55. Winkler J, Block C, Leibovici L, Faktor J, Pitlik SD. Nasal carriage of Staphylococcus aureus: correlation with hormonal status in women. J Infect Dis 1990;162(6):1400-02.

56. Huijsdens, XW, van Santen-Verheuvel MG, Spalburg E, et al. Multiple cases of familial transmission of community-acquired methicillin-resistant Staphylococcus aureus. J Clin Microbiol 2006;44(8):2994- 96.

57. De Neeling AJ, Van Leeuwen WJ, Schouls LM, et al. Resistance of staphylococci in The Netherlands: surveillance by an electronic network during 1989-1995. J Antimicrob Chemother 1998;41(1):93-101.

58. Diekema, DJ, Pfaller MA, Schmitz FJ, et al. Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997–1999. Clin Infect Dis 2001;32(2): S114-32.

59. Urth T, Juul G, Skov R, Schønheyder HC. Spread of a methicillin-resistant Staphylococcus aureus ST80-IV clone in a Danish community. Infect Control Hosp Epidemiol 2005;26(2):144-49.

60. Skov RL, Jensen KS. Community-associated methicillin-resistant Staphylococcus aureus as a cause of hospital-acquired infections. J Hosp Infect 2009;73(4):364-70.

61. Diep BA, Chambers HF, Graber CJ, et al. Emergence of multidrug-resistant, community-associated, methicillin- resistant Staphylococcus aureus clone USA300 in men who have sex with men. Ann Intern Med 2008;148(4):249-57.

62. Nguyen DM, Mascola L, Bancroft E. Recurring methicillin?resistant Staphylococcus aureus infections in a football team. Emerg Infect Dis 2005;11(4):526-32.

63. Aiello AE, Lowy FD, Wright LN, Larson EL. Meticillin-resistant Staphylococcus aureus among US prisoners and military personnel: review and recommendations for future studies. Lancet Infect Dis 2006;6(6):335-41.

64. Adcock PM, Pastor P, Medley F, Patterson JE, Murphy TV. Methicillin-resistant Staphylococcus aureus in two child care centers. J Infect Dis 1998;178(2):577-80.

65. Carey AJ, Della-Latta P, Huard R, et al. Changes in the molecular epidemiological characteristics of methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit. Infect Control Hosp Epidemiol 2010;31(6):613-19.

66. Albrich WC, Harbarth S. Health-care workers: source, vector, or victim of MRSA? Lancet Infect Dis 2008;8(5):289-01.

67. Giuffrè M, Cipolla D, Bonura C, et al. Epidemic spread of ST1-MRSA-IVa in a neonatal intensive care unit, Italy. BMC pediatr 2012; 12:64.

68. Kaibni MH, Farraj MA, Adwan K, Essawi TA. Community-acquired meticillin-resistant Staphylococcus aureus in Palestine. J Med Microbiol 2009;58(5):644-47.

69. David MD, Kearns AM, Gossain S, Ganner M, Holmes A. Community-associated meticillin-resistant Staphylococcus aureus: nosocomial transmission in a neonatal unit. J Hosp Infect 2006;64(3):44-50.

70. Al-Tawfiq JA. Father-to-infant transmission of community-acquired methicillin- resistant Staphylococcus aureus in a neonatal intensive care unit. Infect Control Hosp Epidemiol 2006;27(6):636-37.

71. Ma XX., Sun DD, Wang S, et al. Nasal carriage of methicillin-resistant Staphylococcus aureus among preclinical medical students: epidemiologic and molecular characteristics of methicillin- resistant S. aureus clones. Diagn Microbiol Infect Dis 2011;70(1):22-30.

72. Chen CS, Chen CY, Huang YC. Nasal carriage rate and molecular epidemiology of methicillin-resistant Staphylococcus aureus among medical students at a Taiwanese university. Int J Infect Dis 2012;16(11): e799-03.

73. Bootsma MCJ, Diekmann O, Bonten MJ. Controlling methicillin- resistant Staphylococcus aureus: quantifying the effects of interventions and rapid diagnostic testing. Proc Natl Acad Sci U S A 2006;103(14):5620-25.

74. Raboud J, Saskin R, Simor A, et al. Modeling transmission of methicillin-resistant Staphylococcus aureus among patients admitted to a hospital. Infect Control Hosp Epidemiol 2005;26(7):607-15.

75. Feng Y, Chen CJ, Su LH, et al. Evolution and pathogenesis of Staphylococcus aureus: lessons learned from genotyping and comparative genomics. FEMS Microbiol Rev 2008;32(1):23-37.

76. Struelens MJ, Hawkey PM, French GL, Witte W, Tacconelli E. Laboratory tools and strategies for methicillin?resistant Staphylococcus aureus screening, surveillance and typing: state of the art and unmet needs. Clin Microbiol Infect 2009;15(2):112-19.

77. Lindsay JA. Staphylococci. In: de Filippis I, McKee ML, editors. Molecular Typing in Bacterial Infections. New York:Springer; 2013. p. 385-405.

78. Malhotra-Kumar S, Haccuria K, Michiels M, et al. Current trends in rapid diagnostics for methicillin-resistant Staphylococcus aureus and glycopeptide-resistant enterococcus species. J Clin Microbiol 2008;46(5):577- 87.

79. Johnson G, Millar MR, Matthews S, et al. Evaluation of BacLite Rapid MRSA, a rapid culture based screening test for the detection of ciprofloxacin and methicillin resistant S. aureus (MRSA) from screening swabs. BMC Microbiol 2006; 6:83.

80. McClure JA, Conly JM, Lau V, et al. Novel multiplex PCR assay for detection of the staphylococcal virulence marker Panton- Valentine leukocidin genes and simultaneous discrimination of methicillin- susceptible from -resistant staphylococci. J Clin Microbiol 2006; 44:1141-44.

81. Francois P, Pittet D, Bento M, et al. Rapid detection of methicillin-resistant Staphylococcus aureus directly from sterile or nonsterile clinical samples by a new molecular assay. J Clin Microbiol 2003;41(1):254-60.

82. Peterson LR, Petzel RA, Clabots CR, Fasching CE, Gerding DN. Medical technologists using molecular epidemiology as part of the infection control team. Diagn Microbiol Infect Dis 1993;16(4):303-11.

83. Stefani S, Chung DR, Lindsay JA, et al. Meticillin-resistant Staphylococcus aureus (MRSA): global epidemiology and harmonisation of typing methods. Int J Antimicrob Agents 2012;39(4):273-82.

84. Harris SR, Cartwright EJ, Török ME et al. Whole-genome sequencing for analysis of an outbreak of meticillin-resistant Staphylococcus aureus: a descriptive study. Lancet Infect Dis 2013;13(2):130-36.

85. Bonofiglio L, Mollerach M, Gardella N. Application of Molecular Typing Methods to the Study of Medically Relevant Gram- Positive Cocci. Gel Electrophoresis– Advanced Techniques 2012;113.

86. Mongkolrattanothai K, Boyle S, Kahana MD, Daum RS. Severe Staphylococcus aureus infections caused by clonally related community-acquired methicillin- susceptible and methicillin-resistant isolates. Clin Infect Dis 2003;37(8):1050- 58.

87. Sabat AJ, Budimir A, Nashev D, et al. Overview of molecular typing methods for outbreak detection and epidemiological surveillance. Euro Surveill 2013;18(4):20380.

88. Shore AC, Coleman DC. Staphylococcal cassette chromosome mec: recent advances and new insights. Int J Med Microbiol 2013;303(6-7):350-59.

89. Zhang K, McClure JA, Elsayed S, Louie T, Conly JM. Novel multiplex PCR assay for characterization and concomitant subtyping of staphylococcal cassette chromosome mec types I to V in methicillin- resistant Staphylococcus aureus. J Clin Microbial 2005;43(10):5026-33.

90. Hallin M, Deplano A, Denis O, et al. Validation of pulsed-field gel electrophoresis and spa typing for long- term, nationwide epidemiological surveillance studies of Staphylococcus aureus infections. J Clin Microbiol 2007;45(1):127-33.

91. Strommenger B, Braulke C, Heuck D, et al. spa typing of Staphylococcus aureus as a frontline tool in epidemiological typing. J Clin Microbiol 2008;46(2):574-81.

92. Harmsen D, Claus H, Witte W, et al. Typing of methicillin-resistant Staphylococcus aureus in a university hospital setting by using novel software for spa repeat determination and database management. J Clin Microbiol 2003;41(12):5442-48.

93. Köser CU, Holden MT, Ellington MJ, et al. Rapid whole-genome sequencing for investigation of a neonatal MRSA outbreak. N Engl J Med 2012;366(24):2267-75.

94. Baba T, Takeuchi F, Kuroda M, et al. Genome and virulence determinants of high virulence community-acquired MRSA. Lancet 2002;359(9320):1819-27.

Downloads

Published

2017-12-08

How to Cite

Lia Natasha Amit, Fong Siew Moy, & Daisy Vanitha John. (2017). CHARACTERISTICS, DETECTION AND TYPING METHODS OF COMMUNITY ACQUIRED METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS (CA-MRSA) – A REVIEW. Malaysian Journal of Public Health Medicine, 17(3), 27–37. https://doi.org/10.37268/mjphm/vol.17/no.3/art.231